Characteristics of experimental therapies
| Profit | Academic | Total | |
| Experimental therapies | 514 | 743 | 1257 |
| Trial phase | Profit | Academic | % of experimental therapies |
| I | 13 | 4 | 1.4 |
| I/II | 46 | 1 | 3.7 |
| II | 61 | 560 | 49.4 |
| II/III | 13 | 5 | 1.4 |
| III | 377 | 159 | 42.6 |
| IV | 4 | 14 | 1.4 |
| Cancer type | Profit | Academic | % of experimental therapies |
| Breast cancer | 34 | 104 | 11.0 |
| Gastrointestinal cancer | 65 | 64 | 10.3 |
| Genitourinary cancer | 203 | 141 | 27.4 |
| Haematological malignancy | 51 | 57 | 8.6 |
| Lung cancer | 84 | 39 | 9.8 |
| Melanoma | 45 | 24 | 5.5 |
| Rare tumours | 32 | 314 | 27.5 |